First-in-Human Study of JNJ-79635322 (JNJ-5322), a Novel Next-Generation Trispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Initial Phase 1 Results
Por:
Lee, H, Popat, R, Touzeau, C, Perrot, A, Anguille, S, Oriol, A, Kint, N, Caers, J, Minnema, MC, Kaiser, M, Garfall, A, Matous, J, Sanchez, L, Borogovac, A, Karlin, L, Rosinol, L, Roeloffzen, W, Usmani, S, Varga, C, Pan, D, Ishida, T, Minnick, P, Smit, MD, Daskalakis, N, Prior, T, Krevvata, M, Nguyen, A, Hilder, B, Jonathan, D, Weidman, J, Lee, S, Mateos, MV, Rodriguez-Otero, P, Vega, G and van de Donk, NWCJ
Publicada:
1 sep 2025
Resumen:
Filiaciones:
Lee, H:
Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
Popat, R:
Univ Coll London Hosp NHS Fdn Trust, Natl Inst Hlth Res, Clin Res Facil, London, England
Touzeau, C:
Ctr Hosp Univ Nantes, Nantes, France
Perrot, A:
Univ Toulouse, Univ Paul Sabatier, Inst Univ Canc Toulouse Oncopole, Serv Hematol,CHU Toulouse, Toulouse, France
Anguille, S:
Univ Antwerp, Antwerp Univ Hosp, Div Hematol, Antwerp, Belgium
Univ Antwerp, Antwerp Univ Hosp, Ctr Cell Therapy & Regenerat Med, Antwerp, Belgium
:
Hosp Badalona Germans Trias i Pujol, Inst Catala Oncol, Badalona, Spain
Hosp Germans Trias i Pujol, Inst Josep Carreras, Badalona, Spain
Kint, N:
Ghent Univ Hosp, Dept Hematol, Ghent, Belgium
Caers, J:
CHU Liege, Dept Hematol, Liege, Belgium
Minnema, MC:
Univ Med Ctr Utrecht, Utrecht, Netherlands
Kaiser, M:
Royal Marsden NHS Trust, London, England
Garfall, A:
Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA USA
Matous, J:
Sarah Cannon Res Inst, Colorado Blood Canc Inst, Denver, CO USA
Sanchez, L:
Icahn Sch Med Mt Sinai, New York, NY USA
Borogovac, A:
City Hope Natl Med Ctr, Duarte, CA USA
Karlin, L:
Ctr Hosp Lyon Sud, Serv Hematol Clin, Pierre Benite, France
Rosinol, L:
Univ Barcelona, Hosp Clin, Dept Hematol, IDIBAPS, Barcelona, Spain
Roeloffzen, W:
Univ Med Ctr Groningen, Groningen, Netherlands
Usmani, S:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Varga, C:
Atrium Hlth, Levine Canc Inst, Dept Hematol, Charlotte, NC USA
Pan, D:
Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA
Ishida, T:
Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan
Minnick, P:
Johnson & Johnson, Spring House, PA USA
Smit, MD:
Enliven Therapeut, Boulder, CO USA
Daskalakis, N:
Johnson & Johnson, Spring House, PA USA
Prior, T:
Johnson & Johnson, Spring House, PA USA
Krevvata, M:
Johnson & Johnson, Spring House, PA USA
Nguyen, A:
Johnson & Johnson, Spring House, PA USA
Hilder, B:
Johnson & Johnson, Spring House, PA USA
Jonathan, D:
Johnson & Johnson, Spring House, PA USA
Weidman, J:
Johnson & Johnson, Spring House, PA USA
Lee, S:
Johnson & Johnson, Spring House, PA USA
Mateos, MV:
Univ Hosp Salamanca, IBSAL CIC CIBERONC, Salamanca, Spain
Rodriguez-Otero, P:
Univ Navarra, Clin DISN, CIMA, CIBERONC,IA, Pamplona, Spain
Vega, G:
Hosp Fdn Jimenez Diaz, Div Hematol, START Madrid FJD, Madrid, Spain
van de Donk, NWCJ:
Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands
|